tirzepatide nash phase 3 Nearly 62% achieve MASH resolution without worsening of fibrosis with tirzepatide for nash phase 3

While both medications showed a significant weight loss benefit, after 72 weeks on treatment, people treated with Zepbound lost 20% of their body weight, compared to people on Wegovy who lost just under 14%

Shop strategically

Focus on protein-first eating with 20-35g per meal to preserve muscle mass during weight loss

Uses U-100 insulin syringe standard (100 units = 1mL) Formula: Units = (Dose mg Concentration mg/mL) 100 Supports both mg/mL and mg/0.5mL label formats Sources: FDA Mounjaro & Zepbound prescribing information Confusing mg/mL with mg/0.5mL: If your vial says "5mg/0.5mL", that's actually 10mg/mL